Skip to main content
. Author manuscript; available in PMC: 2021 Nov 10.
Published in final edited form as: J Control Release. 2020 Aug 1;327:174–185. doi: 10.1016/j.jconrel.2020.07.040

Table 3.

Pharmacokinetic parameters of CP-125.

Compound Route Dose (mg/kg) t1/2(h) AUC0 – ∞(μM h) F (%)
CP-125 (pure) i.v. 3 0.9 ± 0.1 4.1 ± 0.3 100
p.o. 15 1.4 ± 0.2 1.3 ± 0.4 6.3
CP-125 (from CO-125) p.o. 25 1.0 ± 0.1 1.1 ± 0.3

t1/2: terminal half-life; AUC0 – ∞: area under the plasma drug concentration curve from time zero to infinity; F: bioavailability. Results are presented as the mean ± SD (n ≥ 3).